| Ytd | 49.99% | |
| 1y | 43.87% |
| Open | 1.50 | Prev Close | 1.47 | Low | 1.33 | High | 1.60 | Mkt Cap | 53.56M |
| Vol | 211.19K | Avg Vol | 320.88K | EPS | -0.23 | P/E | -6.39 | Forward P/E | -5.59 |
| Beta | 1.15 | Short Ratio | 6.73 | Inst. Own | 16.01% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 0.85 | 200-d Avg | 0.90 | 1yr Est | 7.50 |
DYAI News
Gainers China Pharma Holding (AMEX:CPHI) shares increased by 713.2% to $7.4 during Tuesday's re
JUPITER, Fla., July 16, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) ("Dyadic"
Global Collaborations Continue to Validate Dyadic's C1 Platform and Expand Commercial Opportunity Dy
The Japan Patent Office allowed claims covering novel aspects of Dyadic’s proprietary Thermothelomyc
JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic”
SmallCaps Daily Sits Down with Joe Hazelton to Discuss Dyadic's Product Strategy, Strategic Partners
JUPITER, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI), d/b/a Dy
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
JUPITER, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic,” “we,” “us,” “o
JUPITER, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “o
Company invites individual and institutional investors, as well as advisors and analysts, to attend
JUPITER, Fla. , May 19, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic," "we," "us," "
Dyadic International, Inc. (DYAI) Q1 2026 Earnings Call Transcript
Received initial purchase orders for recombinant bovine transferrin from customers in the cultivated
JUPITER, Fla., April 29, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied Bi
Dyadic International, Inc. (DYAI) Q4 2025 Earnings Call Transcript
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using D
JUPITER, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”,
JUPITER, Fla., March 11, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied Bi
JUPITER, Fla. and BENGALURU, India, March 04, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (
Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Da
JUPITER, Fla. and ANKENY, Iowa, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyad
Monday saw 196 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report
Stocks That Hit 52-Week Lows On Wednesday